Investigating the effects of sodium dodecyl sulfate on the aggregative behavior of hen egg-white lysozyme at acidic pH

Colloids and Surfaces B: Biointerfaces

Volumn 81, Issue 1, 2010, Pages 141-151

  Hung, Ying Tz ^a   Lin, Ming Shen ^b   Chen, Wen Yih ^b   Wang, Steven Sheng Shih ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL CENTRAL UNIVERSITY   (Taiwan)

Author keywords

Aggregation; Amyloid fibril; Fibrillation; Hen lysozyme; Sodium dodecyl sulfate

Indexed keywords

AGGREGATION; AMYLOID FIBRIL; FIBRILLATION; HEN LYSOZYME; SODIUM DODECYL SULFATE;

CONCENTRATION (PROCESS); GLYCOPROTEINS; PH EFFECTS; SODIUM; SODIUM SULFATE; UREA;

ENZYMES;

AMYLOID; DODECYL SULFATE SODIUM; EGG WHITE; LYSOZYME;

ACIDITY; ARTICLE; BINDING KINETICS; CIRCULAR DICHROISM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME CONFORMATION; ENZYME RELEASE; ENZYME STABILITY; HYDROPHOBICITY; ISOTHERMAL TITRATION CALORIMETRY; LIGHT SCATTERING; MOLECULAR INTERACTION; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN SECONDARY STRUCTURE; STATIC ELECTRICITY; SURFACE PROPERTY; SURFACE TENSION; THERMODYNAMICS; TRANSMISSION ELECTRON MICROSCOPY;

ACIDS; ANIMALS; CALORIMETRY; CHICKENS; CIRCULAR DICHROISM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HYDROGEN-ION CONCENTRATION; MICROSCOPY, ELECTRON, TRANSMISSION; MURAMIDASE; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STABILITY; PROTEIN STRUCTURE, SECONDARY; SODIUM DODECYL SULFATE; SPECTROMETRY, FLUORESCENCE; THERMODYNAMICS; UREA;

EID: 77956012715     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2010.07.001     Document Type: Article

References (67)

1. Chiti F., Webster P., Taddei N., Clark A., Stefani M., Ramponi G., Dobson C.M. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl. Acad. Sci. U.S.A. 1999, 96(7):3590-3594.
2. Singh S.M., Panda A.K. Solubilization and refolding of bacterial inclusion body proteins. J. Biosci. Bioeng. 2005, 99(4):303-310.
3. Morozova-Roche L., Malisauskas M. A false paradise - mixed blessings in the protein universe: the amyloid as a new challenge in drug development. Curr. Med. Chem. 2007, 14(11):1221-1230.
4. Uversky V.N., Fink A.L. Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim. Biophys. Acta 2004, 1698(2):131-153.
5. Wang S.S.S., Good T.A. An overview of Alzheimer's disease. J. Chin. Inst. Chem. Eng. 2005, 36(6):533-559.
6. Goedert M., Spillantini M.G. A century of Alzheimer's disease. Science 2006, 314(5800):777-781.
7. Bennett M.C. The role of alpha-synuclein in neurodegenerative diseases. Pharmacol. Ther. 2005, 105(3):311-331.
8. Kurtin W.E., Lee J.M. The free energy of denaturation of lysozyme - an undergraduate experiment in biophysical chemistry. Biochem. Mol. Biol. Educ. 2002, 30(4):244-247.
9. Dobson C.M. Principles of protein folding, misfolding and aggregation. Semin. Cell Dev. Biol. 2004, 15(1):3-16.
10. Ferrao-Gonzales A.D, Souto S.O., Silva J.L., Foguel D. The preaggregated state of an amyloidogenic protein: hydrostatic pressure converts native transthyretin into the amyloidogenic state. Proc. Natl. Acad. Sci. U.S.A. 2000, 97(12):6445-6450.
11. Estrada L.D., Soto C. Disrupting beta-amyloid aggregation for Alzheimer disease treatment. Curr. Top. Med. Chem. 2007, 7(1):115-126.
12. Porat Y., Abramowitz A., Gazit E. Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem. Biol. Drug Des. 2006, 67(1):27-37.
13. Gazova Z., Bellova A., Daxnerova Z., Imrich J., Kristian P., Tomascikova J., Bagelova J., Fedunova D., Antalik M. Acridine derivatives inhibit lysozyme aggregation. Eur. Biophys. J. Biophys. Lett. 2008, 37(7):1261-1270.
14. Klunk W.E., Debnath M.L., Koros A.M., Pettegrew J.W. Chrysamine-G, a lipophilic analogue of Congo red, inhibits a beta-induced toxicity in PC12 cells. Life Sci. 1998, 63(20):1807-1814.
15. Howlett D.R, Perry A.E., Godfrey F., Swatton J.E., Jennings K.H., Spitzfaden C., Wadsworth H., Wood S.J., Markwell R.E. Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans. Biochem. J. 1999, 340:283-289.
16. Tomiyama T., Kaneko H., Kataoka K., Asano S., Endo N. Rifampicin inhibits the toxicity of pre-aggregated amyloid peptides by binding to peptide fibrils and preventing amyloid-cell interaction. Biochem. J. 1997, 322(Pt 3):859-865.
17. Tomiyama T., Shoji A., Kataoka K., Suwa Y., Asano S., Kaneko H., Endo N. Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger. J. Biol. Chem. 1996, 271(12):6839-6844.
18. Lomakin A., Chung D.S., Benedek G.B., Kirschner D.A., Teplow D.B. On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. Proc. Natl. Acad. Sci. U.S.A. 1996, 93(3):1125-1129.
19. Wood S.J., MacKenzie L., Maleeff B., Hurle M.R., Wetzel R. Selective inhibition of Abeta fibril formation. J. Biol. Chem. 1996, 271(8):4086-4092.
20. Ono K., Yoshiike Y., Takashima A., Hasegawa K., Naiki H., Yamada M. Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease. J. Neurochem. 2003, 87(1):172-181.
21. De Felice F.G., Vieira M.N., Saraiva L.M., Figueroa-Villar J.D., Garcia-Abreu J., Liu R., Chang L., Klein W.L., Ferreira S.T. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization. FASEB J. 2004, 18(12):1366-1372.
22. Liu R., Barkhordarian H., Emadi S., Park C.B., Sierks M.R. Trehalose differentially inhibits aggregation and neurotoxicity of beta-amyloid 40 and 42. Neurobiol. Dis. 2005, 20(1):74-81.
23. Vaney M.C., Maignan S., Ries-Kautt M., Ducriux A. High-resolution structure (1.33 a) of a hew lysozyme tetragonal crystal grown in the APCF apparatus. Data and structural comparison with a crystal grown under microgravity from Spacehab-01 mission. Acta Crystallogr. D: Biol. Crystallogr. 1996, 52(Pt. 3):505-517.
24. Krebs M.R., Wilkins D.K., Chung E.W., Pitkeathly M.C., Chamberlain A.K., Zurdo J., Robinson C.V., Dobson C.M. Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the beta-domain. J. Mol. Biol. 2000, 300(3):541-549.
25. Frare E., de Laureto P.P., Zurdo J., Dobson C.M., Fontana A. A highly amyloidogenic region of hen lysozyme. J. Mol. Biol. 2004, 340(5):1153-1165.
26. Mishra R., Sorgjerd K., Nystrom S., Nordigarden A., Yu Y.C., Hammarstrom P. Lysozyme amyloidogenesis is accelerated by specific nicking and fragmentation but decelerated by intact protein binding and conversion. J. Mol. Biol. 2007, 366(3):1029-1044.
27. Booth D.R., Sunde M., Bellotti V., Robinson C.V., Hutchinson W.L., Fraser P.E., Hawkins P.N., Dobson C.M., Radford S.E., Blake C.C.F., Pepys M.B. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 1997, 385(6619):787-793.
28. Pepys M.B., Hawkins P.N., Booth D.R., Vigushin D.M., Tennent G.A., Soutar A.K., Totty N., Nguyen O., Blake C.C., Terry C.J., et al. Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature 1993, 362(6420):553-557.
29. Wang W. Protein aggregation and its inhibition in biopharmaceutics. Int. J. Pharm. 2005, 289(1-2):1-30.
30. Moren A.K., Khan A. Phase-equilibria of an anionic surfactant (sodium dodecyl-sulfate) and an oppositely charged protein (lysozyme) in water. Langmuir 1995, 11(10):3636-3643.
31. Li Y.J., Cao M.W., Wang Y.L. Alzheimer amyloid beta(1-40) peptide: interactions with cationic gemini and single-chain surfactants. J. Phys. Chem. B 2006, 110(36):18040-18045.
32. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 1985, 150(1):76-85.
33. LeVine H. Thioflavinet interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 1993, 2(3):404-410.
34. Liu C.P., Li Z.Y., Huang G.C., Perrett S., Zhou J.M. Two distinct intermediates of trigger factor are populated during guanidine denaturation. Biochimie 2005, 87(11):1023-1031.
35. Smoot A.L., Panda M., Brazil B.T., Buckle A.M., Fersht A.R., Horowitz P.M. The binding of bis-ANS to the isolated groel apical domain fragment induces the formation of a folding intermediate with increased hydrophobic surface not observed in tetradecameric groel. Biochemistry 2001, 40(14):4484-4492.
36. Sirangelo I., Bismuto E., Tavassi S., Irace G. Apomyoglobin folding intermediates characterized by the hydrophobic fluorescent probe 8-anilino-1-naphthalene sulfonate (ANS). Biochim. Biophys. Acta - Protein Struct. Mol. Enzymol. 1998, 1385(1):69-77.
37. Semisotnov G.V., Rodionova N.A., Razgulyaev O.I., Uversky V.N., Gripas A.F., Gilmanshin R.I. Study of the " Molten globule" intermediate state in protein folding by a hydrophobic fluorescent probe. Biopolymers 1991, 31(1):119-128.
38. Cooper A., Kennedy M.W., Fleming R.I., Wilson E.H., Videler H., Wokosin D.L., Su T.J., Green R.J., Lu J.R. Adsorption of frog foam nest proteins at the air-water interface. Biophys. J. 2005, 88(3):2114-2125.
39. Green R.J., Su T.J., Joy H., Lu J.R. Interaction of lysozyme and sodium dodecyl sulfate at the air-liquid interface. Langmuir 2000, 16(13):5797-5805.
40. Gohain B., Sarma S., Dutta R.K. Protonated dye-surfactant ion pair formation between neutral red and anionic surfactants in aqueous submicellar solutions. J. Mol. Liq. 2008, 142(1-3):130-135.
41. Barratt E., Bingham R.J., Warner D.J., Laughton C.A., Phillips S.E., Homans S.W. Van der waals interactions dominate ligand-protein association in a protein binding site occluded from solvent water. J. Am. Chem. Soc. 2005, 127(33):11827-11834.
42. Velazquez-Campoy A., Todd M.J., Freire E. HIV-1 protease inhibitors: enthalpic versus entropic optimization of the binding affinity. Biochemistry 2000, 39(9):2201-2207.
43. Ward W.H., Holdgate G.A. Isothermal titration calorimetry in drug discovery. Prog. Med. Chem. 2001, 38:309-376.
44. Rainaldi M., Yamniuk A.P., Murase T., Vogel H.J. Calcium-dependent and -independent binding of soybean calmodulin isoforms to the calmodulin binding domain of tobacco mapk phosphatase-1. J. Biol. Chem. 2007, 282(9):6031-6042.
45. Brockhaus M., Ganz P., Huber W., Bohrmann B., Loetscher H.R., Seelig J. Thermodynamic studies on the interaction of antibodies with beta-amyloid peptide. J. Phys. Chem. B 2007, 111(5):1238-1243.
46. Leavitt S., Freire E. Direct measurement of protein binding energetics by isothermal titration calorimetry. Curr. Opin. Struct. Biol. 2001, 11(5):560-566.
47. Chen S.H., Teixeira J. Structure and fractal dimension of protein-detergent complexes. Phys. Rev. Lett. 1986, 57(20):2583-2586.
48. Otzen D.E., Sehgal P., Westh P. Alpha-lactalbumin is unfolded by all classes of surfactants but by different mechanisms. J. Colloid Interface Sci. 2009, 329(2):273-283.
49. Ghosh S. Interaction of trypsin with sodium dodecyl sulfate in aqueous medium: a conformational view. Colloids Surface B: Biointerfaces 2008, 66(2):178-186.
50. Nielsen M.M., Andersen K.K., Westh P., Otzen D.E. Unfolding of beta-sheet proteins in SDS. Biophys. J. 2007, 92(10):3674-3685.
51. Timasheff S.N. Protein hydration, thermodynamic binding, and preferential hydration. Biochemistry 2002, 41(46):13473-13482.
52. Madaeni S.S., Rostami E. Spectroscopic investigation of the interaction of BSA with cationic surfactants. Chem. Eng. Technol. 2008, 31(9):1265-1271.
53. Kelley D., McClements D.J. Interactions of bovine serum albumin with ionic surfactants in aqueous solutions. Food Hydrocolloids 2003, 17(1):73-85.
54. Lin S.J., Shiao Y.J., Chi C.W., Yang L.M. Abeta aggregation inhibitors. Part 1: synthesis and biological activity of phenylazo benzenesulfonamides. Bioorg. Med. Chem. Lett. 2004, 14(5):1173-1176.
55. Marcinowski K.J., Shao H., Clancy E.L., Zagorski M.G. Solution structure model of residues 1-28 of the amyloid beta peptide when bound to micelles. J. Am. Chem. Soc. 1998, 120(43):11082-11091.
56. Ahmad M.F., Ramakrishna T., Raman B., Rao C.M. Fibrillogenic and non-fibrillogenic ensembles of SDS-bound human alpha-synuclein. J. Mol. Biol. 2006, 364(5):1061-1072.
57. Cao M.W., Han Y.C., Wang J.B., Wang Y.L. Modulation of fibrillogenesis of amyloid beta(1-40) peptide with cationic gemini surfactant. J. Phys. Chem. B 2007, 111(47):13436-13443.
58. Kumar S., Ravi V.K., Swaminathan R. How do surfactants and DTT affect the size, dynamics, activity and growth of soluble lysozyme aggregates?. Biochem. J. 2008, 415:275-288.
59. Mustafi D., Smith C.M., Makinen M.W., Lee R.C. Multi-block poloxamer surfactants suppress aggregation of denatured proteins. Biochim. Biophys. Acta - Gen. Subjects 2008, 1780(1):7-15.
60. Yamamoto S., Hasegawa K., Yamaguchi I., Tsutsumi S., Kardos J., Goto Y., Gejyo F., Naiki H. Low concentrations of sodium dodecyl sulfate induce the extension of beta(2)-microglobulin-related amyloid fibrils at a neutral pH. Biochemistry 2004, 43(34):11075-11082.
61. Rangachari V., Reed D.K., Moore B.D., Rosenberry T.L. Secondary structure and interfacial aggregation of amyloid-beta(1-40) on sodium dodecyl sulfate micelles. Biochemistry 2006, 45(28):8639-8648.
62. Sureshbabu N., Kirubagaran R., Jayakumar R. Surfactant-induced conformational transition of amyloid beta-peptide. Eur. Biophys. J. Biophys. Lett. 2009, 38(4):355-367.
63. McLaughlin R.W., De Stigter J.K., Sikkink L.A., Baden E.M., Ramirez-Alvarado M. The effects of sodium sulfate, glycosaminoglycans, and Congo red on the structure, stability, and amyloid formation of an immunoglobulin light-chain protein. Protein Sci. 2006, 15(7):1710-1722.
64. Pertinhez T.A., Bouchard M., Smith R.A.G., Dobson C.M., Smith L.J. Stimulation and inhibition of fibril formation by a peptide in the presence of different concentrations of SDS. FEBS Lett. 2002, 529(2-3):193-197.
65. Kremer J.J., Sklansky D.J., Murphy R.M. Profile of changes in lipid bilayer structure caused by beta-amyloid peptide. Biochemistry 2001, 40(29):8563-8571.
66. Micelli S., Meleleo D., Picciarelli V., Stoico M.G., Gallucci E. Effect of nanomolar concentrations of sodium dodecyl sulfate, a catalytic inductor of alpha-helices, on human calcitonin incorporation and channel formation in planar lipid membranes. Biophys. J. 2004, 87(2):1065-1075.
67. Salay L.C., Qi W., Keshet B., Tamm L.K., Fernandez E.J. Membrane interactions of a self-assembling model peptide that mimics the self-association, structure and toxicity of a beta(1-40). Biochim. Biophys. Acta - Biomembr. 2009, 1788(9):1714-1721.